Angiotensin 1-7
- Generic Name
- Angiotensin 1-7
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C41H62N12O11
- CAS Number
- 51833-78-4
- Unique Ingredient Identifier
- IJ3FUK8MOF
- Background
TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury
- Conditions
- Interventions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 90
- Registration Number
- NCT06282965
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Biomarker Study: Heart Failure Patients at Risk
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 40
- Registration Number
- NCT05336175
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸Banner - University Medical Center, Phoenix, Arizona, United States
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2021-01-22
- Lead Sponsor
- Rambam Health Care Campus
- Target Recruit Count
- 120
- Registration Number
- NCT04605887
- Locations
- 🇮🇱
Rambam Medical Center, Haifa, Israel
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
- First Posted Date
- 2020-04-03
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Erasme University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04332666
Angiotensin-(1-7) in Peripheral Arterial Disease
- Conditions
- Interventions
- First Posted Date
- 2017-08-04
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 6
- Registration Number
- NCT03240068
- Locations
- 🇺🇸
Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive Subjects
- First Posted Date
- 2016-12-23
- Last Posted Date
- 2016-12-23
- Lead Sponsor
- Instituto de Cardiologia do Rio Grande do Sul
- Target Recruit Count
- 32
- Registration Number
- NCT03001271
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
- Conditions
- Interventions
- First Posted Date
- 2014-09-19
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 24
- Registration Number
- NCT02245230
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
- First Posted Date
- 2008-09-23
- Last Posted Date
- 2012-02-29
- Lead Sponsor
- US Biotest, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT00757250
- Locations
- 🇺🇸
LAC+USC Medical Center, Rand Schrader Clini, Los Angeles, California, United States
🇺🇸UCSD Division of Infectious Diseases, San Diego, California, United States
🇺🇸Harbor - UCLA Medical Center, Torrance, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.